Institut Regional du Cancer de Montpellier

Institut Regional du Cancer de Montpellier is a research organisation in Montpellier Cedex 5, France that has taken part in 7 EU-funded projects since 2013, receiving €2.4M in EU funding and leading 2 as coordinator.

EU funding received€2.4M
EU projects7
As coordinator2
Running now5
First EU project2013
Latest project2027
CountryFrance
EU registration (PIC)949811585
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Institut Regional du Cancer de Montpellier's own share of each project, not the project's full budget.

  • Horizon Europe€1.7M · 4 projects
  • Horizon 2020€398k · 1 project
  • FP7 (2007 to 2013)€315k · 1 project
  • EU4Health Programme (EU4H)€0 · 1 project

Projects

7 EU-funded projects, newest first. Institut Regional du Cancer de Montpellier led 2 of them as coordinator. Each links to the official record.

  • PRIMOCoordinator

    Precision Reasoning In Multimodal Ovarian cancer

    Horizon Europe · 2027–2028 · Project on CORDIS ↗

    €150ktheir share
  • IMPACT-OCPartner

    Interpretable Multimodal Predictive Agents and Digital Twins for Ovarian Cancer

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €450ktheir share
  • IMPACTPartner

    IMproving the outcome of Peritoneal and Pleural metastases using Aerosolized ChemoTherapy

    Horizon Europe · 2026–2032 · Project on CORDIS ↗

    €572ktheir share
  • EUnetCCC JAAssociated partner

    The European Comprehensive Cancer Centre Network

    EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

  • MR O MICSCoordinator

    Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €537ktheir share
  • LIMAPartner

    Liquid biopsies and Imaging for improved cancer care

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €398ktheir share
  • REQUITEPartner

    Validating predictive models of radiotherapy toxicity to improve quality-of-life and reduce side-effects in cancer survivors

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €315ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • breast cancer
  • genetics
  • histology
  • history
  • lung cancer
  • machine learning
  • magnetic resonance imaging
  • oncology
  • pathology
  • pharmaceutical drugs
  • surgery

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime